Enanta Pharmaceuticals | Liquidités

Cash And Equivalent Changement Date
AbbVie USD 13.29B 4.53B 2023-09
Amgen USD 10.94B 23.8B 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Incyte USD 3.21B 13.85M 2023-12
Insmed USD 482.37M 4.74M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Ligand Pharmaceuticals USD 22.95M 3.68M 2023-12
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Roche Holding CHF 3.72B 1.27B 2023-06
Sarepta Therapeutics USD 541.93M 310M 2023-09
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09



Enanta Pharmaceuticals Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.